Europe Pharmacogenetics Testing in Psychiatry Depression Market size is expected to be USD 648.50 million rising at a market growth of 8.9% CAGR during the forecast period
Europe pharmacogenetics testing in psychiatry/depression market is expected to reach the value of USD 648.50 million by 2029, at a CAGR of 8.9% during the forecast period. Anxiety accounts for the largest type segment in the market due to the increasing depression rate among the Europe population. By employing definite steps to collect, record, and analyse market data, the universal EUROPE...
0 Comments 0 Shares 1223 Views 0 Reviews